vioform-hydocortisone 3/1 %w/w %w/w cream
novartis consumer health uk limited - clioquinol hydrocortisone - cream - 3/1 %w/w %w/w
betnovate c
glaxosmithkline nz limited - betamethasone valerate 0.1%{relative} (0.122% with overage); clioquinol 3%{relative} - topical ointment - active: betamethasone valerate 0.1%{relative} (0.122% with overage) clioquinol 3%{relative} excipient: liquid paraffin white soft paraffin - betnovate-c preparations are indicated for the treatment of the following conditions where secondary bacterial and/or fungal infection is present, suspected or likely to occur:- eczema including atopic, and discoid eczemas. prurigo nodularis. psoriasis (excluding widespread plaque psoriasis). neurodermatoses including lichen simplex, lichen planus. seborrhoeic dermatitis. contact sensitivity reactions. insect bite reactions. prickly heat. anal and genital intertrigo. otitis externa.
ala quin- hydrocortisone and iodochlorhydroxyquin cream
crown laboratories - hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj), clioquinol (unii: 7bhq856ej5) (clioquinol - unii:7bhq856ej5) - hydrocortisone 5 mg in 1 g - based on a review of this drug by the national academy of sciences-national research council and/or other information, fda has classified the indications as follows: “possibly” effective: contact or atopic dermatitis; impetiginized eczema; nummular eczema; infantile eczema; endogenous chronic infectious dermatitis; stasis dermatitis; pyoderma; nuchal eczema and chronic eczematoid otitis externa; acne urticata; localized or disseminated neurodermatitis; lichen simplex chronicus; anogenital pruritus (vulvae, scroti, ani); folliculitis; bacterial dermatoses; mycotic dermatoses such as tinea (capitis, cruris, corporis, pedis); moniliasis; intertrigo. final classification of the less-than-effective indications requires further investigation. hypersensitivity to lodochlorhydroxyquin-hydrocortisone, or any of its ingredients or related compounds: lesions of the eye, tuberculosis of the skin; most viral skin lesions (including herpes simplex, vaccinia, and varicella). patients sensitive to chloroxine, iodine, or iodi
locacorten vioform cream
amdipharm limited amdipharm limited, temple chambers, 3 burlington - flumetasone pivalate and clioquinol bp - cream - flumethasone pivalate 0.2% and clioquinol 3% - otological corticosteroids and anti-infectives in
locacorten vioform ear drops ear drops, solution
amdipharm limited amdipharm limited, temple chambers, 3 burlington - flumetasone pivalate and clioquinol bp - ear drops, solution - flumetasone pivalate 0.02% w/v and clioquinol bp - ophthalmological and otological preparation:
locacorten - vioform ear drops
jaffar pharmacy - clioquinol-1.0 %w/v, flumetasone pivalate-0.020 %w/v - ear drops
neo vagex tablet
neolab inc - acetarsol; clioquinol; benzalkonium chloride - tablet - 100mg; 50mg; 2mg - acetarsol 100mg; clioquinol 50mg; benzalkonium chloride 2mg - miscellaneous antifungals
hydroderm-c cream 1%
icm pharma pte. ltd. - clioquinol; hydrocortisone acetate - cream - 3% w/w - clioquinol 3% w/w; hydrocortisone acetate 1% w/w
locacorten - vioform cream
jaffar pharmacy - clioquinol, flumethasone - cream
locacorten - vioform ointment
jaffar pharmacy - clioquinol, flumethasone - ointment